From: Circulating chemokine ligand levels before and after successful kidney transplantation
Parameter | Pre-TX | Post-TX | P value |
---|---|---|---|
Number | 47 | 47 | Â |
Male (n) % | (24/47) 51.1 %  |  | |
Female (n) % | (23/47) 48.9 %  |  | |
Patient age | 42.73 ± 14.71 | 49.11 ± 14.53 | 0.049  |
Patient age ≥ 60 (yrs) (n) % | 12.80 % | 25.30 % |  |
Ethnic origin | Â | Â | Â |
 Caucasian |  72.34 % |  | |
 First Nation or Metis |  25.53 % |  | |
 Asian |  2.13 % |  | |
Diabetic nephropathy | 29.78Â % | Â | |
Type of TX (LD/DD) | 13/34 | Â | |
Hemodialysis duration (yrs) | 3.01 (1.72–4.13) | ─ |  |
Duration transplant (yrs) | ─ | 6.51 ± 2.03 |  |
Duration between first and second test (yrs) | 9.82 (9.82–10.14) |  | |
GFR (CKD-EPI) | ─ | 52.1 (38.6–61.3) |  |
GFR (CKD-EPI) ≥ 60 (n %) | ─ | 37.5 % |  |